Compare Abeona Therapeutics Inc (ABEO) vs Monolithic Power Systems Inc (MPWR) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Monolithic Power Systems Inc — how do they compare? Abeona Therapeutics Inc trades at $6.73 (market cap $373.32M), while Monolithic Power Systems Inc trades at $1,321.67 (market cap $62.53B). The key difference: Monolithic Power Systems Inc is far larger — about 167.5× Abeona Therapeutics Inc's market cap, and Monolithic Power Systems Inc pays a 0.63% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | MPWR | |
|---|---|---|
Market Cap | $373.32M | $62.53B |
Sector | Health | Utilities |
52-Week High | $7.23 | $1.69K |
52-Week Low | $4.17 | $711.24 |
Enterprise Value | $228.22M | $61.19B |
Dividend Yield | — | 0.63% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
MPWR trades at $1,346.13, up 4.5% in the past 24 hours, showing strong momentum. The stock exhibits bearish technical signals but benefits from consistent earnings beats and robust profitability, with a net margin of 22.98%. Recent news highlights growth in AI infrastructure and consumer electronics demand. Cash flow remains positive, and a $2.00 dividend is scheduled for July 2026.
Outlook is supported by analyst optimism (88% buy ratings) and a consensus price target of $1,760, though high valuation multiples and ongoing legal investigations pose risks. Revenue growth and AI-driven demand present opportunities, but investors should weigh elevated P/E of 96.36 against potential market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Monolithic Power Systems Inc
Monolithic Power Systems, Inc. is a global leader in high-performance, analog, and mixed-signal semiconductors. The company specializes in power management solutions, providing integrated circuits (ICs) for a wide range of applications, including computing, automotive, industrial, and communications. MPWR's proprietary process technology is designed to deliver highly energy-efficient and compact power solutions, positioning the company as a key supplier for the next generation of electronic devices.
Read more on MPWR →
